Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Like Sands Through The Hourglass, So Are Janet Woodcock’s Days As Acting FDA Commissioner

Jun 23 2021

• By Derrick Gingery

Hourglass

Related Content

Aduhelm Approval Raises Concerns About US FDA Leadership, Senate Finance Chair Suggests

Jun 11 2021

Alzheimer’s Can Follow HIV And Become Chronic Condition If Science Advances, Woodcock Argues

Jun 11 2021

Aduhelm Approval Firestorm Raises Question: What Are US FDA Advisory Committees For, Anyway?

Jun 11 2021

Campaign Against Woodcock’s US FDA Commissioner Bid Has Begun

Jan 29 2021

Woodcock Faces Maze Of Rules To Become Commissioner Nominee

Jan 22 2021

US FDA Faces Succession Questions As Hahn’s Departure Nears

Jan 06 2021

A Return Trip For Kessler At US FDA? It Wouldn’t Be The First Time It’s Happened

Dec 03 2020

Woodcock Has Big, Quiet Supporter In Her Bid For US FDA Commissioner

Feb 06 2021

Former US FDA Commissioners Try To Shake Loose Biden Nomination

Mar 09 2021

FDA Staying The Course Under Ostroff; Hamburg’s Concerns Will Remain Focus

Apr 21 2015

FDA Feels Heat On Drug Pricing And Generic Labeling Rule

Feb 25 2016

Related Companies

Biogen, Inc.

Additional Topics

International United States FDA Leadership Politics Commercial Compliance Enforcement Manufacturing Executive Changes Policy Regulation Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window